Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業のM&A・提携動向(医療分野)

GlobalDataが発行した調査報告書(GDPH139165D)
◆英語タイトル:Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH139165D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年12月19日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers APIs and bulk drugs used in anti-neoplastics. It also offers products for cardiovascular treatment, anti-infection, anti-parasite, endocrine control, immunoinhibitors and anti-depression. Hisun offers active pharmaceutical ingredient such as acarbose, adenosine, bicalutamide, bleomycin a2, b2, bleomycin sulfate, cladribine, cyclophosphmaide, and others. Hisun has research and development facilities in Shanghai and Beijing. The company exports its products to America, Africa, Europe, Oceania and Asia. Hisun is headquartered in Taizhou, China.

Zhejiang Hisun Pharmaceutical Co Ltd (600267) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Zhejiang Hisun Pharmaceutical Co Ltd, Medical Devices Deals, 2010 to YTD 2016 11
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Sagent Pharma Secures US$40 Million In Series B Financing Round 14
Partnerships 14
GeneriCo Enters into Distribution Agreement with Zhejiang Hisun Pharmaceutical 14
Celsion Enters into Agreement with Zhejiang Hisun Pharma 15
Zhejiang Hisun Pharma Enters into Memorandum of Understanding (MoU) with Sanofi 16
Zhejiang Hisun Pharma to Enter Co-Development Agreement with Ambrx 17
Catalent Pharma Enters Into An Agreement With Zhejiang Hisun Pharma To Develop Biosimilars 17
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 18
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 19
Pfizer Forms Joint Venture With Zhejiang Hisun Pharma For Generic Medicines 20
Zhejiang Hisun Pharma to Form Joint Venture With Beijing-Based Technology Company 21
Enzon Pharma Enters Into Co-Development Agreement With Zhejiang Hisun Pharma 22
Zhejiang Hisun Enters Into Co-Development Agreement With PharmTak 23
Licensing Agreements 24
Zhejiang Hisun Pharma Enters into Licensing Agreement with Nascent Biotech 24
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 25
Enzon Pharma Enters Into Licensing Agreement With Zhejiang Hisun Pharma For PEG-SN38 25
Roswell Park Cancer Institute Enters Into Licensing Agreement With Zhejiang Hisun Pharma 26
Equity Offering 27
Zhejiang Hisun Pharma Receives Regulatory Approval for Private Placement of Shares 27
Zhejiang HISUN Pharma Plans Private Placement For US$203 Million 28
Debt Offering 29
Zhejiang Hisun Pharma Prices Private Placement of Bonds for USD184 Million 29
Zhejiang Hisun Pharma to Raise USD128.6 Million in First Tranche of Public Offering of Bonds 29
Zhejiang Hisun Pharma Announces Private Placement Of Notes For Up To US$327 Million 30
Zhejiang Hisun Pharma Announces Public Offering Of Bonds 31
Acquisition 31
Zhejiang Hisun Pharma to Acquire 68% Stake in China Based Pharma Company for USD24.5 Million 31
Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 32
Zhejiang Hisun Pharma to Acquire 15% Stake in Zhejiang-Based Pharma Company for USD12 Million 32
Zhejiang Hisun Pharma Acquires Respirics, Respiratory Drug Developer 33
Zhejiang Hisun To Invest In Photolitec 34
Zhejiang Hisun Pharmaceutical Co Ltd – Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Zhejiang Hisun Pharmaceutical Co Ltd, Deals By Therapy Area, 2010 to YTD 2016 9
Zhejiang Hisun Pharmaceutical Co Ltd, Medical Devices Deals, 2010 to YTD 2016 11
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
Sagent Pharma Secures US$40 Million In Series B Financing Round 14
GeneriCo Enters into Distribution Agreement with Zhejiang Hisun Pharmaceutical 14
Celsion Enters into Agreement with Zhejiang Hisun Pharma 15
Zhejiang Hisun Pharma Enters into Memorandum of Understanding (MoU) with Sanofi 16
Zhejiang Hisun Pharma to Enter Co-Development Agreement with Ambrx 17
Catalent Pharma Enters Into An Agreement With Zhejiang Hisun Pharma To Develop Biosimilars 17
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 18
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 19
Pfizer Forms Joint Venture With Zhejiang Hisun Pharma For Generic Medicines 20
Zhejiang Hisun Pharma to Form Joint Venture With Beijing-Based Technology Company 21
Enzon Pharma Enters Into Co-Development Agreement With Zhejiang Hisun Pharma 22
Zhejiang Hisun Enters Into Co-Development Agreement With PharmTak 23
Zhejiang Hisun Pharma Enters into Licensing Agreement with Nascent Biotech 24
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 25
Enzon Pharma Enters Into Licensing Agreement With Zhejiang Hisun Pharma For PEG-SN38 25
Roswell Park Cancer Institute Enters Into Licensing Agreement With Zhejiang Hisun Pharma 26
Zhejiang Hisun Pharma Receives Regulatory Approval for Private Placement of Shares 27
Zhejiang HISUN Pharma Plans Private Placement For US$203 Million 28
Zhejiang Hisun Pharma Prices Private Placement of Bonds for USD184 Million 29
Zhejiang Hisun Pharma to Raise USD128.6 Million in First Tranche of Public Offering of Bonds 29
Zhejiang Hisun Pharma Announces Private Placement Of Notes For Up To US$327 Million 30
Zhejiang Hisun Pharma Announces Public Offering Of Bonds 31
Zhejiang Hisun Pharma to Acquire 68% Stake in China Based Pharma Company for USD24.5 Million 31
Zhejiang Hisun Pharma Plans to Divest Stake in Sagent Pharma 32
Zhejiang Hisun Pharma to Acquire 15% Stake in Zhejiang-Based Pharma Company for USD12 Million 32
Zhejiang Hisun Pharma Acquires Respirics, Respiratory Drug Developer 33
Zhejiang Hisun To Invest In Photolitec 34
Zhejiang Hisun Pharmaceutical Co Ltd, Key Competitors 36
Zhejiang Hisun Pharmaceutical Co Ltd, Key Employees 37
Zhejiang Hisun Pharmaceutical Co Ltd, Subsidiaries 38

List of Figures
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Zhejiang Hisun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Zhejiang Hisun Pharmaceutical Co Ltd, Medical Devices Deals, 2010 to YTD 2016 11

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業のM&A・提携動向(医療分野)(Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆